Five-year, Multicenter Safety Study of Fixed-combination Latanoprost/Timolol (Xalacom) for Open-angle Glaucoma and Ocular Hypertension

Journal of Glaucoma, 04/11/2011

After 5 years, more than 70% of participants treated with fixed–combination latanoprost/timolol had no increased iris pigmentation. The fixed combination is safe and well tolerated for long–term treatment in patients with open–angle glaucoma or ocular hypertension.

Print Article Summary Cat 2 CME Report